Key Highlights
- MDB reached a new 52-week peak at $447.00, now trading near $452.89
- Shares have surged 114% in the past twelve months
- Oppenheimer increased its target from $410 to $475 while keeping its Outperform designation
- Several firms including Needham, Tigress Financial, and Stifel have lifted their forecasts
- GF Value metrics indicate MDB is approximately 14% overvalued relative to fair value estimates
Shares of MongoDB (MDB) reached a 52-week peak of $447.00 on August 13, with the stock currently changing hands at $452.89. This impressive climb represents a 114% appreciation over the trailing twelve-month period, capturing significant attention from market participants.
The most recent catalyst arrived via Oppenheimer, which on August 12 elevated its price objective for MDB from $410 to $475 while maintaining its Outperform stance. This represents a 15.85% increase in the firm’s valuation outlook.
Additional Wall Street voices echo this optimistic sentiment. Needham established a $430 price objective, emphasizing artificial intelligence expenditures as a favorable driver for MongoDB’s business. Tigress Financial adopted an even more aggressive posture with a $515 target, underscoring the company’s strategic positioning within AI-driven data infrastructure markets.
Stifel lifted its forecast to $435, crediting robust Atlas platform expansion and improving consumption dynamics. Cantor Fitzgerald maintained its Overweight designation alongside a $416 target, emphasizing MongoDB’s critical function within the AI data ecosystem.
The first-quarter financial performance that sparked much of this enthusiasm revealed Atlas expansion of 29%, surpassing projections by roughly 3 percentage points. Overall revenue exceeded consensus estimates by $23.1 million.
Financial Metrics Analysis
MongoDB’s current market capitalization hovers around $35.2 billion. Year-over-year revenue expansion for the trailing twelve months approaches 24%. The price-to-sales multiple registers approximately 16.3x, closely aligned with its historical median of 16.28x.
However, profitability remains elusive. The company’s trailing twelve-month earnings per share stands at -$0.37, rendering traditional price-to-earnings metrics inapplicable.
According to GF Value methodology, the stock’s intrinsic worth is calculated at $387.49, implying MDB currently trades roughly 13.7% above this benchmark. The company’s GF Score registers 83 out of 100, reflecting robust growth and momentum characteristics, though offset by a modest profitability ranking of 3 out of 10.
Trading Activity Among Insiders and Institutions
A notable counterpoint exists in the data. Corporate insiders have liquidated $53.7 million in shares during the past three months, with no offsetting insider purchases documented during this timeframe.
On the institutional front, 10 prominent investors maintain MDB positions, with 4 expanding their stakes while 7 have reduced exposure. The ownership landscape presents a divided picture.
Citigroup, Truist Securities, and Bank of America have each sustained Buy recommendations accompanied by upward target adjustments. This widespread analyst support maintains an optimistic backdrop notwithstanding the insider disposition activity.
The company’s GF Score of 83 highlights solid underlying fundamentals regarding expansion and price momentum, while simultaneously identifying profitability challenges as a persistent concern.
Oppenheimer’s updated $475 price objective stands among the most current analytical benchmarks available, issued on August 12, 2026.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
